The pre-operative briefing had been running for four minutes when the scrub tech asked about the insertion sequence for the new fixation system. The surgeon answered. The circulating nurse made a note. The case started on time and ran without hesitation. That four-minute conversation prevented the kind of mid-case pause that costs twice as long and carries ten times the cognitive load.

Team-based pre-operative preparation is one of the most underused performance tools in surgical practice. Not because surgeons do not value it, but because the structure for making it consistent and productive is rarely built into the workflow. When it is, the difference shows up in case flow, team confidence, and the quality of intraoperative decisions.

What effective pre-case preparation covers

A productive pre-operative briefing is not a full device in-service. It is a focused, time-efficient alignment around the specific case at hand. It covers the device or implant being used, the insertion or application sequence, the anatomical considerations relevant to this patient, and any aspects of the procedure where the team’s response needs to be synchronised.

For cases involving devices that are new to the team or used less frequently, that briefing also surfaces knowledge gaps before the case rather than during it. A scrub tech who asks a question in the briefing room contributes to the case. The same question asked at the instrument table creates friction.

The role of shared device knowledge

Intraoperative hesitation is almost never about skill. It is about uncertainty. A team that has collectively reviewed the device, the sequence, and the expected intraoperative milestones operates with a shared mental model that reduces the cognitive load on every member, including the surgeon.

Synchrocare’s medical sales consultants are trained to support pre-operative preparation as part of their clinical role, not just the initial in-service. That includes being available for pre-case reviews, providing technique guides and procedure summaries that teams can use in briefings, and answering device-specific questions before the patient is on the table.

Building the habit across your team

The facilities where team-based preparation is most consistent are the ones that have made it structural rather than optional. A five-minute standing briefing before the first case of a new device, a shared procedure summary posted in the scrub room, and a pre-case checklist that includes device-specific items. These are small investments that compound over time.

For surgical services directors and lead surgeons building high-performance teams, pre-operative device preparation is as important as any other component of surgical competency. The training that happens before the case determines how much thinking the team has to do during it.

To learn more about Synchrocare’s clinical support and pre-operative resources, visit www.synchrocare.com.

Scaling national distribution for a medical device is one of the most capital-intensive challenges a manufacturer faces after FDA clearance. Hiring, training, credentialing, and managing a direct sales force across multiple states requires headcount, overhead, and time that most companies cannot absorb at the pace the market demands. The alternative, a distribution partner with an established national network, addresses that challenge, but only if the network is built on the right foundations.

Synchrocare’s franchise model is designed specifically to create exactly this kind of network. Each franchise owner is a trained, compliant, market-ready representative operating within an established distribution infrastructure. For manufacturers evaluating national expansion, understanding what that model delivers is the starting point for evaluating whether Synchrocare is the right partner.

Each franchise owner is a credentialed market entry point

A Synchrocare franchise owner enters their market having completed a comprehensive training program covering product knowledge, procedure-relevant anatomy, surgical technique considerations, and the full compliance framework, including the AdvaMed Code of Ethics, the Stark Law, the Anti-Kickback Statute, and the False Claims Act. Every owner undergoes a thorough background check and maintains industry-standard insurance before entering any facility.

For a manufacturer adding their product to Synchrocare’s portfolio, each franchise territory represents immediate access to a trained, credentialed representative who is already known to local hospitals, ambulatory surgery centers, and surgeons. The groundwork of clinical relationship-building and facility credentialing has been laid before your product arrives in the territory. That compression of the market entry timeline is one of the most concrete advantages of the network model for manufacturers.

Clinical depth that protects your product’s reputation in the field

National distribution that lacks clinical depth creates its own risks for manufacturers. A representative who cannot speak credibly about the anatomy, the surgical technique, and the clinical rationale behind a device does not just underperform. They actively damage the surgeon’s confidence in the product. One poor clinical interaction early in a territory can set adoption back by months.

Synchrocare’s training model addresses this by ensuring that every franchise owner understands not just how to use a product but why it is designed the way it is and what clinical problems it is engineered to solve. That depth is what earns standing in the OR and what sustains surgeon relationships through the learning curve of a new device introduction.

Compliance infrastructure that protects you

A distributor’s compliance failures do not stay with the distributor. Violations of the Stark Law, the Anti-Kickback Statute, or the False Claims Act create liability that travels back to the manufacturer whose products were involved. Every Synchrocare franchise owner operates within Synchrocare’s compliance framework, with documented training, background checks, and insurance as non-negotiable standards across the entire network.

For manufacturers who have invested years in building a product and a clinical reputation, that compliance foundation is not a courtesy. It is a structural protection for everything you have built.

To learn more about partnering with Synchrocare as your national distribution partner, visit www.synchrocare.com.

Most people evaluating a medical device franchise spend the majority of their time on two questions: how much does it cost, and how much can I earn – both matter. Neither one tells you whether the franchise model you are looking at will actually give you what you need to build a sustainable, growing business. The questions that determine that are rarely the first ones asked.

Before you sign anything, here is the framework worth applying to any medical device franchise opportunity, including this one.

Start with the product portfolio

A franchise is only as strong as the products it gives you access to. Evaluate the portfolio the same way you would evaluate any device before using it clinically: what clinical problems does it address, how strong is the evidence behind it, what is the FDA clearance status of each product, and does the portfolio serve multiple surgical specialties or depend heavily on a single indication?

Synchrocare’s portfolio spans twelve manufacturer partners covering orthopedic fixation, spine and extremity surgery, advanced wound care, orthobiologics, regenerative medicine, and bone grafting. That breadth means franchise owners are not dependent on a single clinical trend or a single surgical relationship. It also means you enter facilities as a resource across multiple service lines, which deepens your value to the hospitals and ASCs you work with.

Evaluate the training program before you trust the territory

The quality of the training program determines the quality of the franchise owner that comes out of it. Ask specifically what the program covers: product knowledge only, or also anatomy, surgical technique, and compliance? How long does it run? What is the assessment process? Is there ongoing education after initial training or a single in-service, and then you are on your own?

Synchrocare’s medical sales consultant training program covers product knowledge, the steps in the sales process from start to finish, procedure-relevant anatomy, surgical technique considerations, and the full compliance framework, including the AdvaMed Code of Ethics, the Stark Law, the Anti-Kickback Statute, and the False Claims Act. Background checks and insurance requirements apply across the network. Every franchise owner completes that program before entering any facility.

Understand the compliance infrastructure

Compliance in medical device sales is not a background consideration. It governs how you enter facilities, how you engage with surgeons, how you run sales activities, and how you document everything. A franchise model with a weak compliance infrastructure exposes you personally and professionally.

Ask any franchise you evaluate: what compliance training is provided, how it is updated as regulations change, and what happens when a compliance question arises in the field. The answer tells you a great deal about how seriously the franchisor takes the regulatory environment you will be operating in.

Clarify what ownership actually means

Not all franchise agreements treat ownership the same way. Some give you a territory in name but retain the right to reassign or restructure it. Some tie your equity to performance metrics you do not control. Read the agreement carefully and understand specifically what you own, what you can sell, and under what conditions the relationship can be restructured.

The Synchrocare franchise model is built on the premise that the work of building a territory should belong to the person who did it. Before you commit to any franchise, make sure you understand exactly what that commitment creates and what you walk away with if you ever choose to exit. Is the opportunity you are evaluating built on that same premise?

To learn more about the Synchrocare franchise opportunity, visit www.synchrocare.com/franchising.

Five years from now, the medical sales professionals who made the most of this decade will not only be the ones who hit the highest commission numbers, they will be the ones who built something. A territory with depth. Surgeon relationships with genuine loyalty. A business with real equity and a growth trajectory they control.

Building that kind of territory requires more than clinical knowledge and sales skill, though both matter. It requires a deliberate approach to territory development from the first day of market entry, and it requires the structural support to execute that approach consistently over time. That is what the Synchrocare franchise model provides.

Territory planning starts before the first call

The most productive territories in medical device sales are not built by making the most calls. They are built by making the right calls in the right sequence. Before your first day in the market, Synchrocare’s training program gives you a clear picture of the product portfolio, the clinical indications that drive demand, and the facility types and surgical specialties where each product has the strongest fit.

That preparation lets you enter your territory with a prioritization framework rather than a contact list. You know which facilities have the highest concentration of relevant surgical volume, which specialties your portfolio serves most directly, and which surgeon profiles are most likely to engage early. That focus in the first six months determines the trajectory of the next five years.

Depth before breadth in relationship development

New franchise owners sometimes feel pressure to cover as much ground as possible, as quickly as possible. The territories that build the strongest long-term value do the opposite. They go deep in a manageable number of facilities before expanding outward. A surgeon who trusts you completely in one hospital is worth more to your territory than five surgeons who know your name in five different ones.

Depth comes from consistent presence, clinical preparedness, and the kind of follow-through that makes a surgeon confident their patients are well supported after every case. Synchrocare’s back-office infrastructure, customer service support, and ongoing clinical resources give franchise owners the operational backing to deliver that level of follow-through without it consuming all their capacity.

Building equity that compounds

Every strong surgeon relationship a Synchrocare franchise owner builds accrues to their business. Every facility where their compliance record is clean and their clinical support is consistent adds to the value of the territory they are developing. Unlike a traditional sales role where that value belongs to an employer, a franchise owner’s equity compounds in their own name.

The Synchrocare franchise model is built on the premise that the people who do the work of building a territory should own what they build. The network provides the portfolio, the infrastructure, the training, and the purchasing power. The franchise owner provides the clinical credibility and the relationship depth that no infrastructure can substitute.

In five years, which side of that equation do you want to be on?

To learn more about the Synchrocare franchise opportunity, visit www.synchrocare.com/franchising.

Two surgeons. Same training program. Same patient population. Meaningfully different long-term outcomes. The difference, more often than clinical data suggests, is not technical skill. It is how deliberately each one evaluates and selects the devices they use.

Device selection in surgical practice is rarely treated as a formal discipline. It happens through exposure, through rep relationships, through what is available on contract at a given facility. The surgeons who produce the most consistent outcomes over time approach it differently. They ask different questions before a device earns a place in their practice.

Start with an indication fit

Every device has an indication profile. The surgeons who use devices well match that profile precisely to their patient before the case, not during it. A device that performs excellently within its indicated use performs unpredictably outside it.

Reviewing indication criteria against your patient’s specific anatomy, pathology, and risk profile before selecting a device is the first discipline. It is also the one most frequently compressed under scheduling pressure.

Read the clinical evidence yourself.

Published clinical evidence on a device tells you more than a rep presentation. It tells you which patient populations were studied, what the follow-up period was, what the comparator was, and where the variance in outcomes appeared. Those details determine whether the data applies to your patients.

Synchrocare provides peer-reviewed publications and clinical data for every product in its portfolio. The expectation is not that surgeons will accept the data uncritically. It is that they will engage with it and use it to make better-informed decisions for individual patients.

Evaluating technique demands honestly

Some devices have a steeper learning curve than their IFU suggests. The honest evaluation of a device includes an honest evaluation of where you are on that curve and what support you need to use it at the level the clinical evidence assumes.

Synchrocare’s medical sales consultants are trained to support surgeons through the learning curve on new devices with ongoing case support, technique guidance, and access to clinical resources beyond the initial in-service. That support is built into every product partnership, not offered as an optional add-on.

Track your own outcomes

The surgeons with the clearest picture of which devices serve their patients best are the ones tracking their own outcomes systematically. Complication rates, revision rates, patient-reported function scores, and return to activity timelines tell you things that published studies cannot, because they reflect your specific patient population and your specific technique.

Building that data discipline into your practice takes time. It returns compounding value across a career.

To learn more about Synchrocare’s clinical support resources and product portfolio, visit www.synchrocare.com.

$50,000+

The estimated average cost of a single preventable surgical complication, including additional care, extended stay, and administrative burden. Source: AHRQ data.

Purchase price is the number procurement teams see most clearly. It appears on every vendor proposal, drives most contract negotiations, and is the easiest variable to compare across competing distributors. It is also the smallest part of what a medical device relationship actually costs a facility over time.

The administrators who manage device relationships most effectively think in total cost of ownership. They account for the variables that do not appear on a purchase order but show up in complication rates, staff training hours, OR delays, and compliance incidents. Understanding that the full picture is what turns a procurement decision into a strategic one.

The cost of inadequate clinical support after the sale

When a device enters a facility without adequate clinical support, the cost of that gap falls on the facility. Clinical educators spend hours filling in training gaps that a distributor’s in-service should have covered. Circulating nurses field questions; they should not need to ask. Surgeons work around knowledge gaps in their teams that slow procedure times and increase cognitive load.

Synchrocare’s medical sales consultants provide comprehensive in-service training, ongoing technique support, and access to technique guides, case studies, and clinical FAQs across every product in the portfolio. That continuity of support reduces the internal resource burden on facilities and keeps teams competent on devices long after the initial product introduction.

The cost of compliance exposure from under-qualified representatives

A distributor representative who enters your facility without proper credentialing, adequate insurance, or training on the regulatory standards governing their conduct creates institutional exposure. A single compliance incident, a Stark Law violation, an Anti-Kickback Statute issue, or a breach of the AdvaMed Code of Ethics does not stay with the distributor. It travels to the facility.

Every Synchrocare medical sales consultant undergoes a thorough background check, maintains industry-standard insurance, and completes training on every applicable compliance standard before entering any facility. All activities are conducted in full compliance with applicable regulations and industry standards. For compliance officers who manage vendor credentialing, that documented foundation reduces both risk and administrative overhead.

The cost of supply chain gaps in high-volume surgical schedules

OR scheduling depends on the reliable availability of the instruments and implants that those cases require. A distributor whose order management and customer service infrastructure cannot sustain that reliability creates a cost that is felt directly in the OR. Cases get rescheduled. Staff time is consumed managing exceptions. Surgeons lose confidence in products they associate with supply problems rather than clinical performance.

Synchrocare provides back-office and customer service support specifically designed to keep supply chains reliable for the hospitals and ambulatory surgery centers it serves. For administrators managing high-volume surgical schedules, operational reliability is not a secondary consideration. It is a direct contributor to OR efficiency and revenue consistency.

To learn more about how Synchrocare supports hospital and ASC operations, visit www.synchrocare.com.

In 1851, a small Swiss company began producing collagen-based materials in Wolhusen. That company is Geistlich. What started as Switzerland’s first glue factory grew, over more than a century and a half, into one of the most scientifically credentialed regenerative biomaterials companies in the world. Today, a Geistlich product is used every 14 seconds globally. More than 2,800 peer-reviewed publications underpin their product portfolio. That depth of evidence does not happen by accident.

Synchrocare distributes Geistlich products as part of its national specialty medical device portfolio, giving surgeons and healthcare facilities in the United States access to this technology through trained, compliant medical sales consultants.

Here is what orthopedic and sports medicine surgeons should know about what Geistlich brings to bone and cartilage regeneration.

Geistlich focuses on regenerative, minimally invasive methods and the development of products that support self-healing processes in the body.

Orthoss is Geistlich’s bone graft substitute for orthopedic applications. It is bio-engineered to closely resemble the inorganic component of human bone tissue, with a unique pore structure that mirrors the architecture of natural bone. This internal structure gives Orthoss an inner surface area similar to that of autologous bone, which supports bone regeneration by providing an osteoconductive environment for cell ingrowth.

To repair bone defects, autografts are still widely considered the gold standard, but autografts carry documented risks, including donor site morbidity and limited availability. Orthoss provides an alternative that avoids those trade-offs, is available off the shelf in unlimited quantities, and comes in various sizes and formats. The product has a global history demonstrating safety across orthopedic indications, and has been validated in collaboration with surgeons across multiple clinical settings.

Cartilage repair built on a decade of evidence

Articular cartilage has a limited capacity to heal itself. Without adequate blood supply and with low chondrocyte mitogenic potential, cartilage defects left untreated progress over time and frequently lead to osteoarthritis. Geistlich developed Chondro-Gide to address this directly.

Chondro-Gide is a highly purified collagen membrane with a specifically engineered bilayer structure. The rough, porous bottom layer supports cell colonization and tissue ingrowth. The smooth, compact top layer faces the joint cavity and prevents progenitor cells from diffusing out of the defect site into the joint space, where they would be lost to the regeneration process. The membrane is biocompatible and fully resorbable, replaced by native tissue as healing progresses.

Used in the AMIC technique, Autologous Matrix-Induced Chondrogenesis, Chondro-Gide is applied over a bone marrow stimulation site to create a biological chamber that stabilizes the superclot and provides the conditions for new cartilage tissue to form. AMIC with Chondro-Gide is a single-step, minimally invasive procedure performable by mini-open or arthroscopic methods. Clinical applications include the knee, talus, hip, and first metatarsophalangeal joint.

More than ten years of clinical data support the effectiveness of Chondro-Gide in cartilage repair. A randomized controlled trial published in the International Orthopaedics journal demonstrated sustained benefit of AMIC over microfracture alone at five years. In a three-arm study of 47 patients, pain and function scores for the microfracture-only group deteriorated significantly after two years, while AMIC outcomes remained stable or improved. Geistlich Pharma data on file and published clinical studies.

Chondro-Gide has also received Breakthrough Device Designation from the US Food and Drug Administration, a recognition that the product addresses an unmet clinical need and offers new, more effective treatment options for patients with serious joint conditions.

A Swiss company with a global scientific foundation

Geistlich is a privately held, family-owned Swiss company that has been manufacturing biomaterials of the highest quality in Wolhusen since 1899. The company has 15 international affiliates and a large global distribution network. Its commitment to scientific rigor is formalized through three independent foundations: the Osteology Foundation in dentistry, the Osteo Science Foundation in North America, and the ON Foundation in orthopedics, all dedicated to independent research and education in regenerative medicine.

To learn more about Geistlich products available through Synchrocare, visit www.synchrocare.com.

The strongest medical device territories are not built by the best salespeople. They are built by the people surgeons trust most.

That distinction matters more in medical device sales than in almost any other sales environment. A surgeon who does not trust that a sales consultant understands their patients, their anatomy, and the clinical decisions they are making will not give that consultant meaningful access to their OR. No amount of relationship management compensates for clinical credibility in that room. The representatives who build lasting territories are the ones who think like clinicians, even though they are not.

Clinical thinking is a learnable discipline

Thinking like a clinician in medical device sales does not mean diagnosing patients or advising on surgical technique. It means understanding the anatomy relevant to the procedures your products are used in. It means knowing the clinical indication criteria well enough to support appropriate patient selection conversations. It means being able to discuss the published evidence behind a device, not just its features.

These skills are trainable, and Synchrocare’s medical sales consultant training program builds them deliberately. Every franchise owner completes training on product knowledge, procedure-relevant anatomy, surgical technique considerations, and the full compliance framework before entering the market. That foundation is what separates a Synchrocare franchise owner from a rep who learned the product on the job.

How clinical knowledge builds durable surgeon relationships

Surgeons operate in high-stakes environments where every decision is consequential. When a medical sales consultant brings information that is clinically relevant, grounded in evidence, and delivered with a genuine understanding of what the surgeon is trying to achieve for their patient, the nature of that relationship changes.

It moves from vendor to trusted resource. That shift does not happen through social skills alone. It happens through the kind of clinical knowledge that makes a rep genuinely useful in and around the OR, not just at a lunch meeting. Franchise owners who invest in that knowledge from the beginning build relationships that generate consistent, long-term territory value.

What ownership adds to the equation

A clinically knowledgeable employee and a clinically knowledgeable franchise owner cover the same ground differently. The owner has a stake in every relationship they build. When a surgeon trusts a Synchrocare franchise owner, that trust accrues to a business the owner controls, not to an employer who can reassign the territory on thirty days’ notice.

The Synchrocare franchise model provides the portfolio, the infrastructure, the compliance support, and the purchasing power of a national network. What the franchise owner brings is the clinical credibility and relationship depth that no infrastructure can manufacture. Those two things together are what build a territory worth owning.

The medical device industry rewards that combination generously and consistently. The question is whether you are positioned to receive that reward as an owner or as someone who is building it for someone else.

To learn more about the Synchrocare franchise opportunity, visit www.synchrocare.com/franchising.

Value-based care models tie reimbursement directly to patient outcomes, care quality, and cost efficiency. For hospital systems and ambulatory surgery centers operating under these frameworks, every vendor relationship either contributes to those goals or creates friction against them. A specialty medical device distributor whose clinical standards, product portfolio, and support infrastructure are aligned with outcome-focused care is not just a supplier. It is a partner in the model.

Most procurement decisions treat medical device distribution as a cost center. Value-based care invites a different question: how does this distributor relationship affect the quality of care we deliver and the cost of delivering it?

Devices that support better outcomes reduce the total cost of care

Value-based care frameworks penalize complications, readmissions, and revision surgeries. They reward facilities where patients recover well, return to function faster, and require fewer follow-up interventions. The devices used in those outcomes are not separate from the equation. They are central to it.

Synchrocare selects manufacturer partners whose products address genuine clinical needs, have strong safety profiles, and are supported by clinical evidence. Every device in Synchrocare’s portfolio is FDA-approved and distributed with the clinical support infrastructure needed to ensure appropriate use. That selectivity, choosing fewer products that meet a high standard rather than distributing broadly without clinical depth, is what protects your facility’s outcome data.

Clinical support that reduces complications and follow-up costs

Complications related to inadequate device training and suboptimal patient selection are among the most preventable cost drivers in surgical care. A distributor whose medical sales consultants are comprehensively trained on product knowledge, procedure-relevant anatomy, and appropriate patient selection criteria reduces that risk at the point closest to the patient.

Synchrocare’s medical sales consultants complete rigorous training before entering any facility and remain available for clinical support across the entire lifecycle of a product relationship. Technique guides, case studies, and in-service resources are provided as standard across every product in the portfolio. For administrators tracking complication rates and readmission data, the quality of that clinical support is directly relevant to those numbers.

Compliance infrastructure that protects your institutional standing

Under value-based care contracting, institutional compliance is audited more rigorously than it was under traditional fee-for-service models. Vendor relationships that create compliance exposure, through inadequately trained representatives, missing credentials, or non-standard conduct, carry institutional risk that falls directly on the facility.

Every Synchrocare medical sales consultant undergoes a thorough background check, maintains industry-standard insurance, and is trained on the AdvaMed Code of Ethics, the Stark Law, the Anti-Kickback Statute, and the False Claims Act before entering any facility. All activities are conducted in full compliance with applicable regulations and industry standards. For compliance officers and procurement teams operating under increased scrutiny, that foundation is a meaningful risk reduction.

A distributor relationship built for the long term

Value-based care rewards consistency. Facilities that deliver reliable outcomes over time, supported by stable vendor relationships with high clinical standards, build the kind of performance record that translates into stronger contracting positions and better reimbursement rates. Synchrocare’s model, a selective product portfolio, trained and compliant field representatives, and back-office infrastructure that keeps supply chains reliable, is designed to support exactly that kind of consistency.

To learn more about how Synchrocare supports hospital and ASC value-based care goals, visit www.synchrocare.com.